Fanconi Cancer Foundation Research Grant Awards
Funds innovative research on Fanconi anemia, focusing on cancer pathogenesis, treatment, gene therapy, and quality of life improvements through interdisciplinary and translational science.
Funder: Fanconi Cancer Foundation
Due Dates (Anticipated): March 2027 (Letter of Intent) | June 2027 (Full Proposal)
Funding Amounts: $25,000–$250,000 per award for 1–2 year projects; milestone-based funding
Summary: Supports innovative, translational, and interdisciplinary research to advance understanding, treatment, and cures for Fanconi anemia.
Description
The Fanconi Cancer Foundation Research Grant Awards fund interdisciplinary and translational research projects focused on Fanconi anemia (FA). The foundation seeks proposals that address key research priorities, including the pathogenesis of FA-associated cancers, strategies for prevention, early detection, treatment, and cure, as well as gene therapy, bone marrow failure, systemic and aging manifestations, quality of life improvements, data analytics for biomarker identification, and resource sharing. Both preclinical and clinical research projects are eligible. The program is designed to support high-impact, innovative projects that may not be funded by traditional sources, with a strong emphasis on advancing scientific knowledge and clinical care for individuals with FA.
